Search This Blog

Pages

Thursday, 26 September 2019

Cashing in on dementia patients: drugmaker to pay $116 million in fraud settlement

A pharmaceutical company that whistleblowers alleged paid doctors to prescribe its main drug and urged salespeople to push it as a way to control unruly dementia patients will pay more than $100 million to settle government fraud allegations.

from CNN.com - RSS Channel - App International Edition https://ift.tt/2logTsS

No comments:

Post a Comment

Riders' clothing checked at women's Tour over bra padding concerns

Officials at the Tour de France Femmes Avec Zwift will check the clothing worn by riders to prevent attempts to make "aerodynamic gains...